LPS activates the toll-like receptor 4 (TLR4) signaling pathway to trigger pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-α, which are the risk factors causing the development of T2DM [33–34]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.